Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|4|1|121-128

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.4, Iss.1, 2006-01, pp. : 121-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Factor Xa Inhibitors for Venous Thromboembolism Prevention in Major Orthopedic Surgery: A Review

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 5, 2009-12 ,pp. : 217-226

Karger

Access to resources Recommend Favorite

Extended Prophylaxis against Venous Thromboembolism following Total Hip and Knee Replacement

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 23-31

Karger

Access to resources Recommend Favorite

Clinical and cost outcomes of venous thromboembolism in Medicare patients undergoing total hip replacement or total knee replacement surgery

By Baser Onur Supina Dylan Sengupta Nishan Wang Li Kwong Louis

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 423-429

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery

By Martin Michelle T. Nutescu Edith A.

Current Medical Research and Opinion, Vol. 27, Iss. 11, 2011-11 ,pp. : 2123-2131

Informa Healthcare

Access to resources Recommend Favorite

Warfarin prophylaxis in patients after total knee or hip arthroplasty – international normalized ratio patterns and venous thromboembolism

By Nordstrom Beth L. Kachroo Sumesh Fraeman Kathy H. Nutescu Edith A. Schein Jeff R. Fisher Alan Bookhart Brahim K.

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1973-1985

Informa Healthcare

Access to resources Recommend Favorite